OMC
Overbrook Management Corp Portfolio holdings
AUM
$536M
This Quarter Return
+11.08%
1 Year Return
+33.2%
3 Year Return
+122.08%
5 Year Return
+205.37%
10 Year Return
+409.63%
AUM
$421M
AUM Growth
+$421M
(+10%)
Cap. Flow
+$5.27M
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
57.41%
Holding
82
New
6
Increased
7
Reduced
33
Closed
14
Top Buys
| 1 |
Ares Management
ARES
|
$12.7M |
| 2 |
Microchip Technology
MCHP
|
$10.6M |
| 3 |
Visa
V
|
$9.29M |
| 4 |
Intuit
INTU
|
$8.12M |
| 5 |
Advanced Micro Devices
AMD
|
$6.02M |
Top Sells
| 1 |
Bank of America
BAC
|
$16.6M |
| 2 |
Mohawk Industries
MHK
|
$14.6M |
| 3 |
Constellium
CSTM
|
$7.99M |
| 4 |
Johnson & Johnson
JNJ
|
$1.13M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$1.12M |
Sector Composition
| 1 | Technology | 36.73% |
| 2 | Financials | 20.16% |
| 3 | Healthcare | 14.71% |
| 4 | Communication Services | 12.17% |
| 5 | Consumer Discretionary | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$96.7B
| $341K | 0.08% |
5,340
-400
| -7% | -$25.6K |
|
52
McDonald's
MCD
$226B
| $328K | 0.08% |
1,100
| – | – |
|
53
Morgan Stanley
MS
$237B
| $321K | 0.08% |
3,764
| – | – |
|
54
Champions Oncology
CSBR
$95.8M
| $309K | 0.07% |
48,488
| – | – |
|
55
Golub Capital BDC
GBDC
$3.91B
| $287K | 0.07% |
21,223
+6,121
| +41% | +$82.6K |
|
56
SPDR Gold Trust
GLD
$111B
| $270K | 0.06% |
1,515
| – | – |
|
57
Procter & Gamble
PG
$370B
| $266K | 0.06% |
1,756
| – | – |
|
58
PepsiCo
PEP
$203B
| $265K | 0.06% |
1,431
-650
| -31% | -$120K |
|
59
Celldex Therapeutics
CLDX
$1.57B
| $263K | 0.06% |
7,763
| – | – |
|
60
Pfizer
PFE
$141B
| $251K | 0.06% |
6,852
-2,425
| -26% | -$88.9K |
|
61
Vanguard Value ETF
VTV
$143B
| $250K | 0.06% |
1,756
-3,262
| -65% | -$464K |
|
62
GE Aerospace
GE
$293B
| $224K | 0.05% |
+2,038
| New | +$224K |
|
63
Vanguard Short-Term Bond ETF
BSV
$38.3B
| $223K | 0.05% |
2,949
-1,236
| -30% | -$93.4K |
|
64
Precision Optics
POCI
$35.3M
| $201K | 0.05% |
+32,704
| New | +$201K |
|
65
ImmuCell
ICCC
$59.1M
| $164K | 0.04% |
32,857
| – | – |
|
66
Innovative Solutions & Support
ISSC
$213M
| $105K | 0.02% |
14,575
| – | – |
|
67
IN8bio
INAB
$10M
| $52K | 0.01% |
+33,756
| New | +$52K |
|
|
STRM
68
DELISTED
Streamline Health Solutions
STRM
| $36.5K | 0.01% |
28,762
| – | – |
|
69
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.86B
| – | – |
-8,250
| Closed | -$1.05M |
|
70
Vanguard Growth ETF
VUG
$185B
| – | – |
-1,156
| Closed | -$288K |
|
71
Vanguard Health Care ETF
VHT
$15.5B
| – | – |
-850
| Closed | -$203K |
|
72
Union Pacific
UNP
$132B
| – | – |
-2,074
| Closed | -$417K |
|
73
Thermo Fisher Scientific
TMO
$183B
| – | – |
-525
| Closed | -$303K |
|
74
Stryker
SYK
$149B
| – | – |
-705
| Closed | -$201K |
|
|
75
Mohawk Industries
MHK
$8.11B
| – | – |
-145,186
| Closed | -$14.6M |
|